Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Regulatory News

Date Source Headline
12th May 2017 7:00 am RNS IMFINZI SIGNIFICANT PFS - UNRESECTABLE LUNG CANCER
10th May 2017 7:00 am RNS AZ updates on tralokinumab trial in severe asthma
2nd May 2017 2:00 pm RNS Total Voting Rights
2nd May 2017 7:00 am RNS DURVALUMAB RECEIVES US FDA ACCELERATED APPROVAL
27th Apr 2017 5:30 pm RNS Result of AGM
27th Apr 2017 7:00 am RNS AstraZeneca: Q1 2017 Results
25th Apr 2017 1:30 pm RNS TAGRISSO RECEIVES FULL APPROVAL IN THE EU
12th Apr 2017 5:34 pm RNS Notification of Major Interest in Shares
3rd Apr 2017 3:00 pm RNS Total Voting Rights
31st Mar 2017 7:01 am RNS Tagrisso (osimertinib) receives FDA full approval
31st Mar 2017 7:00 am RNS AZ COMPLETES AGREEMENT WITH TERSERA THERAPEUTICS
28th Mar 2017 4:00 pm RNS Director/PDMR Shareholding
27th Mar 2017 3:00 pm RNS Director/PDMR Shareholding
17th Mar 2017 7:00 am RNS US FDA issues CRL for ZS-9 in hyperkalaemia
16th Mar 2017 11:00 am RNS Notice of AGM
15th Mar 2017 7:00 am RNS LYNPARZA PFS IN BRCA OVARIAN MAINTENANCE THERAPY
8th Mar 2017 7:00 am RNS Filing of Form 20-F with SEC
7th Mar 2017 2:30 pm RNS Annual Financial Report
6th Mar 2017 7:00 am RNS Directorate Change
3rd Mar 2017 7:00 am RNS ALLIANCE WITH SANOFI PASTEUR FOR MEDI8897
1st Mar 2017 4:30 pm RNS Total Voting Rights
28th Feb 2017 7:02 am RNS FDA approves once-daily Qtern for type-2 diabetes
24th Feb 2017 12:32 pm RNS CHMP positive opinion for ZS-9 in hyperkalaemia
20th Feb 2017 7:00 am RNS AZ licenses Zoladex to TerSera for the US & Canada
17th Feb 2017 7:00 am RNS Lynparza positive in metastatic BRCA breast cancer
16th Feb 2017 12:01 pm RNS SILIQ (BRODALUMAB) APPROVED BY US FDA
2nd Feb 2017 7:00 am RNS AZN: FY16 and Q4 2016 Results
1st Feb 2017 4:00 pm RNS Total Voting Rights
26th Jan 2017 10:00 am RNS SYMBICORT GRANTED PAEDIATRIC EXCLUSIVITY IN THE US
17th Jan 2017 7:00 am RNS AZ 1st-line lung cancer immuno-oncology programme
3rd Jan 2017 4:00 pm RNS Total Voting Rights
23rd Dec 2016 7:00 am RNS AZ COMPLETES SALE OF ANTIBIOTICS BUSINESS
16th Dec 2016 1:00 pm RNS Director/PDMR Shareholding
9th Dec 2016 3:05 pm RNS FDA accepts durvalumab for BLA in bladder cancer
6th Dec 2016 9:30 am RNS Tagrisso data shows superiority over chemotherapy
5th Dec 2016 7:00 am RNS AZ completes agreement for Rhinocort Aqua rights
1st Dec 2016 4:00 pm RNS Block listing Interim Review
1st Dec 2016 3:00 pm RNS Total Voting Rights
22nd Nov 2016 7:00 am RNS AZ head and neck cancer trials resume enrolment
17th Nov 2016 7:00 am RNS AZ out-licensing deal with Allergan completed
FTSE 100 Latest
Value8,837.91
Change26.87